Runben Biotechnology (603193.SS) Earnings Analysis
Runben Biotechnology (603193.SS) next reports earnings on 2026-08-21. It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 24.47.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603193.SS next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
603193.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.12 CNY | n/a | n/a | n/a |
| 2025-10-20 | 0.1941 CNY | n/a | n/a | n/a |
| 2025-08-19 | 0.35 CNY | 0.11 CNY | +218.2% | Beat |
| 2025-04-25 | 0.09729 CNY | 0.13 CNY | -25.2% | Miss |
| 2025-04-24 | 0.11 CNY | 0.11 CNY | 0% | Beat |
| 2024-08-15 | 0.3573 CNY | 0.36 CNY | -0.7% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
603193.SS valuation and analyst view
| Trailing P/E | 24.47 |
|---|---|
| Trailing EPS | 0.79818 CNY |
| Price / book | 3.48 |
| Dividend yield | 2.35% |
| Market cap | 7.84B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Runben Biotechnology (603193.SS)'s next earnings date?
Runben Biotechnology is next scheduled to report on 2026-08-21.
Did 603193.SS beat earnings last quarter?
Consensus estimate data was not available for 603193.SS's 2026-04-22 report.
What is 603193.SS's earnings track record?
Over the last 4 reported quarters with consensus data, 603193.SS beat estimates 2 times (50%).
What is 603193.SS's current P/E ratio and EPS?
603193.SS trades at a trailing P/E of 24.47 on trailing EPS of 0.7981834642971881 CNY.
What do analysts rate 603193.SS?
603193.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.